Race-day Lasix was the center of conversation at the Oct. 28 Kentucky Drug and Research Council meeting, and the most controversial item of the day—phasing out Lasix in 2-year-olds and stakes races in Kentucky—was voted down 5-3 by the commitee, which makes medication rule recommendations to the Kentucky Horse Racing Commission.